This letter to the editor acknowledges the contribution of Akbar et al. to the field of tardive dyskinesia (TD) and provides important regulatory information about the potential for parkinson-like symptoms in patients with TD who are treated with valbenazine.
Keywords: Parkinsonism; Prescribing information; Valbenazine.
Copyright © 2020 Elsevier Ltd. All rights reserved.